Cargando…
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
Diabetic macular edema (DME) has shown an increasing prevalence during the past years and is the leading cause of diabetic retinopathy blindness. Traditional treatment modalities include laser and corticosteroid therapy, which, however, either act through unclear mechanisms or cause cataracts and el...
Autores principales: | Cai, Siwei, Yang, Qianhui, Li, Xiaorong, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197825/ https://www.ncbi.nlm.nih.gov/pubmed/30410308 |
Ejemplares similares
-
Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
por: Ba, Teer, et al.
Publicado: (2020) -
Conbercept and Retinal Photocoagulation in the treatment of Diabetic Macular Edema
por: Meng, Weizhe, et al.
Publicado: (2019) -
Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
por: Sun, Xiaolei, et al.
Publicado: (2020) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015)